清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section

非典型腺瘤性增生 医学 腺癌 冰冻切片程序 一致性 淋巴结 肺腺癌 病理 放射科 内科学 癌症
作者
Yang Zhang,Chaoqiang Deng,Fangqiu Fu,Zelin Ma,Zhexu Wen,Xiangyi Ma,Shengping Wang,Yuan Li,Haiquan Chen
出处
期刊:Chest [Elsevier BV]
卷期号:159 (3): 1265-1272 被引量:25
标识
DOI:10.1016/j.chest.2020.10.076
摘要

Background Our previous study revealed that intraoperative frozen section (FS) analysis could differentiate invasive lung adenocarcinoma (LUAD) accurately from preinvasive lesions. However, few articles have analyzed the clinical impact of FS errors such as underestimation of invasive adenocarcinomas (IACs), and whether complementary therapy is needed remains controversial. Research Question What is the prognosis of patients undergoing limited resection for invasive LUAD misdiagnosed as atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), or minimally invasive adenocarcinoma (MIA) by intraoperative FS analysis? Study Design and Methods From 2012 through 2018, data on 3031 patients undergoing sublobar resection of AAH, AIS, or MIA diagnosed by FS analysis were collected. The concordance rate between FS analysis and final pathologic results was evaluated. To assess the clinical significance of a discrepancy between FS and final pathologic results, patients with final pathologic results of IAC were identified for prognostic evaluation. Results When AAH, AIS, and MIA were classified together as a group, the overall concordance rate between FS and final pathologic results was 93.7%, and 192 patients (6.3%) received an upgraded diagnosis from the final pathologic results. Misdiagnosed IACs consisted of 94 patients (48.9%) with lepidic-predominant adenocarcinoma, 77 patients (40.1%) with acinar predominant adenocarcinoma, 19 patients (9.9%) with papillary predominant adenocarcinoma, one patient with solid predominant adenocarcinoma, and one patient with invasive mucinous adenocarcinoma. Among these patients, no positive N1 or N2 lymph node findings were observed. Moreover, the 5-year recurrence-free survival was still 100%, although the final pathologic results turned out to be IAC. Interpretation Patients undergoing limited resection of invasive LUAD misdiagnosed as AAH, AIS, or MIA by FS analysis showed excellent prognoses. Sublobar resection guided by FS diagnosis would be adequate for these underestimated cases of invasive LUAD. Our previous study revealed that intraoperative frozen section (FS) analysis could differentiate invasive lung adenocarcinoma (LUAD) accurately from preinvasive lesions. However, few articles have analyzed the clinical impact of FS errors such as underestimation of invasive adenocarcinomas (IACs), and whether complementary therapy is needed remains controversial. What is the prognosis of patients undergoing limited resection for invasive LUAD misdiagnosed as atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), or minimally invasive adenocarcinoma (MIA) by intraoperative FS analysis? From 2012 through 2018, data on 3031 patients undergoing sublobar resection of AAH, AIS, or MIA diagnosed by FS analysis were collected. The concordance rate between FS analysis and final pathologic results was evaluated. To assess the clinical significance of a discrepancy between FS and final pathologic results, patients with final pathologic results of IAC were identified for prognostic evaluation. When AAH, AIS, and MIA were classified together as a group, the overall concordance rate between FS and final pathologic results was 93.7%, and 192 patients (6.3%) received an upgraded diagnosis from the final pathologic results. Misdiagnosed IACs consisted of 94 patients (48.9%) with lepidic-predominant adenocarcinoma, 77 patients (40.1%) with acinar predominant adenocarcinoma, 19 patients (9.9%) with papillary predominant adenocarcinoma, one patient with solid predominant adenocarcinoma, and one patient with invasive mucinous adenocarcinoma. Among these patients, no positive N1 or N2 lymph node findings were observed. Moreover, the 5-year recurrence-free survival was still 100%, although the final pathologic results turned out to be IAC. Patients undergoing limited resection of invasive LUAD misdiagnosed as AAH, AIS, or MIA by FS analysis showed excellent prognoses. Sublobar resection guided by FS diagnosis would be adequate for these underestimated cases of invasive LUAD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
坏坏的快乐完成签到,获得积分10
21秒前
xrose完成签到 ,获得积分10
38秒前
003完成签到,获得积分10
42秒前
juju1234完成签到 ,获得积分10
53秒前
科研狗完成签到 ,获得积分10
53秒前
002完成签到,获得积分10
1分钟前
1分钟前
001完成签到,获得积分10
1分钟前
vsvsgo完成签到,获得积分10
1分钟前
通科研完成签到 ,获得积分10
1分钟前
个性仙人掌完成签到 ,获得积分10
2分钟前
严珍珍完成签到 ,获得积分10
2分钟前
zhdjj完成签到 ,获得积分10
2分钟前
sysi完成签到 ,获得积分10
2分钟前
桂花完成签到 ,获得积分10
2分钟前
creep2020完成签到,获得积分10
2分钟前
back you up应助科研通管家采纳,获得50
2分钟前
back you up应助科研通管家采纳,获得30
2分钟前
wei完成签到 ,获得积分10
2分钟前
科研小白书hz完成签到 ,获得积分10
3分钟前
3分钟前
大方的笑萍完成签到 ,获得积分10
3分钟前
3分钟前
章铭-111完成签到 ,获得积分10
3分钟前
干亿先完成签到 ,获得积分10
4分钟前
懒大王完成签到 ,获得积分10
4分钟前
长孙归尘完成签到 ,获得积分10
5分钟前
smile完成签到,获得积分10
5分钟前
六一儿童节完成签到 ,获得积分10
5分钟前
Chris完成签到,获得积分10
5分钟前
精明一寡发布了新的文献求助10
5分钟前
czzlancer完成签到,获得积分10
6分钟前
水哥完成签到 ,获得积分10
6分钟前
6分钟前
动漫大师发布了新的文献求助10
6分钟前
yiryir完成签到 ,获得积分10
7分钟前
7分钟前
精明一寡发布了新的文献求助10
7分钟前
Artin完成签到,获得积分10
7分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3779197
求助须知:如何正确求助?哪些是违规求助? 3324782
关于积分的说明 10219874
捐赠科研通 3039903
什么是DOI,文献DOI怎么找? 1668502
邀请新用户注册赠送积分活动 798686
科研通“疑难数据库(出版商)”最低求助积分说明 758503